Sanofi Genzyme – Strategy, SWOT and Corporate Finance Report

Sanofi Genzyme – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Sanofi Genzyme (Genzyme or ‘the company), a specialty care global business unit of Sanofi provides treatments with a focus on rare diseases, multiple sclerosis, immunology, rare blood disorders and oncology. The major products of the company include Aldurazyme, Aubagio, Caprelsa tablets, Alprolix , Cablivi , Eloctate , Lumizyme ,LIBTAYO , Cerdelga capsules, Cerezyme, Clolar, Dupixent injection, Elitek, Eloxatin, Fabrazyme, Jevtana, Kevzara injection, Lemtrada, Lumizyme, , Taxotere injection concentrate, and ZALTRAP injection for intravenous infusion. The company also addresses the unmet needs in immune diseases including atopic dermatitis, rheumatoid arthritis, asthma, nasal polyposis, and eosinophilic esophagitis. The company primarily operates in the Americas and Europe. The company is headquartered in Cambridge, Massachusetts, the US.

Scope

– Detailed information on Sanofi Genzyme required for business and competitor intelligence needs

– A study of the major internal and external factors affecting Sanofi Genzyme in the form of a SWOT analysis

– An in-depth view of the business model of Sanofi Genzyme including a breakdown and examination of key business segments

– Intelligence on Sanofi Genzyme's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

– News about Sanofi Genzyme, such as business expansion, restructuring, and contract wins

– Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Sanofi Genzyme and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess Sanofi Genzyme as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on Sanofi Genzyme's business structure, strategy and prospects.

Table of Contents

Table of Contents

Company Snapshot

Sanofi Genzyme: Company Overview

Sanofi Genzyme: Overview and Key Facts

Sanofi Genzyme: Overview

Sanofi Genzyme: Key Facts

Sanofi Genzyme: Key Employees

Sanofi Genzyme: Key Employee Biographies

Sanofi Genzyme: Major Products and Services

Sanofi Genzyme: Company History

Sanofi Genzyme: Locations and Subsidiaries

Sanofi Genzyme: Key Competitors

Sanofi Genzyme: Company Analysis

Sanofi Genzyme: Business Description

Sanofi Genzyme: SWOT Analysis

Sanofi Genzyme: SWOT Overview

Sanofi Genzyme: Strengths

Sanofi Genzyme: Weaknesses

Sanofi Genzyme: Opportunities

Sanofi Genzyme: Threats

Sanofi Genzyme: Corporate Financial Deals Activity

Sanofi Genzyme: Financial Deals Overview

Sanofi Genzyme: Top Deals 2017 - 2021YTD*

Sanofi Genzyme: Partnership

Sanofi Genzyme: Divestments

Sanofi Genzyme: Recent Developments

Sanofi Genzyme: News and Events Summary

Sanofi Genzyme: Market Developments

Sanofi Genzyme: Regulatory and Legal Events

Sanofi Genzyme: Research & Development

Appendix

Contact Us

Methodology

About MarketLine

List of Tables

List of Tables

Table 1: Sanofi Genzyme: Key Facts

Table 2: Sanofi Genzyme: Key Employees

Table 3: Sanofi Genzyme: Company History

Table 4: Sanofi Genzyme: Locations and Subsidiaries

Table 5: Sanofi Genzyme: Key Competitors

Table 6: Sanofi Genzyme: Deal Activity by Deal Type – Volume (2017 – YTD*2021)

Table 7: Sanofi Genzyme: Top Deals 2017 – 2021YTD*

Table 8: Sanofi Genzyme: Partnership Volume and Value Trend (2017 – YTD*2021)

Table 9: Sanofi Genzyme: Partnership Trend by Deal Type (2017 – YTD*2021)

Table 10: Sanofi Genzyme: Divestments Volume and Value Trend (2017 – YTD*2021)

Table 11: Sanofi Genzyme: News and Events Summary

Table 12: Sanofi Genzyme: Market Developments

Table 13: Sanofi Genzyme: Regulatory and Legal Events

Table 14: Sanofi Genzyme: Research & Development

List of Figures

List of Figures

Figure 1: Sanofi Genzyme: Deal Activity by Deal Type – Volume (2017 – YTD*2021)

Figure 2: Sanofi Genzyme: Partnership Volume and Value Trend (2017 – YTD*2021)

Figure 3: Sanofi Genzyme: Partnership Trend by Deal Type (2017 – YTD*2021)

Figure 4: Sanofi Genzyme: Divestments Volume and Value Trend (2017 – YTD*2021)

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports